Deletion of the adenosine A1 receptor gene does not alter neuronal damage following ischaemia in vivo or in vitro

European Journal of Neuroscience

Volumn 20, Issue 5, 2004, Pages 1197-1204

  Olsson, Tomas ^a   Cronberg, Tobias ^a   Rytter, Anna ^a   Asztély, Fredrik ^b   Fredholm, Bertil B ^c   Smith, Maj Lis ^a   Wieloch, Tadeusz ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Compensatory mechanisms; Global ischaemia; Hippocampal slice culture; Mouse; Neuronal death

Indexed keywords

8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE A1 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; 8-CYCLOPENTYL-1,3-DIMETHYLXANTHINE; DRUG DERIVATIVE; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; GENE DELETION; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIA; KNOCKOUT MOUSE; MALE; MOUSE; NERVE CELL LESION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; WILD TYPE; ANIMAL; BRAIN ISCHEMIA; C57BL MOUSE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; GENETICS; METABOLISM; MOUSE MUTANT; NERVE CELL; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN ISCHEMIA; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; RECEPTOR, ADENOSINE A1; THEOPHYLLINE;

EID: 4344610549     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2004.03564.x     Document Type: Article

References (40)

1. Anderson, R., Sheehan, M.J. & Strong, P. (1994) Characterization of the adenosine receptors mediating hypothermia in the conscious mouse. Br. J. Pharmacol., 113, 1386-1390.
2. Bauman, L.A., Mahle, C.D., Boissard, C.G. & Gribkoff, V.K. (1992) Age-dependence of effects of A1 adenosine receptor antagonism in rat hippocampal slices. J. Neurophysiol., 68, 629-638.
3. Bischofberger, N., Jacobson, K.A. & von Lubitz, D.K. (1997) Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders. Ann. NY Acad. Sci., 825, 23-29.
4. Boris-Moller, F., Smith, M.L. & Siesjo, B.K. (1989) Effects of hypothermia on ischemic brain damage: a comparison between preischemic and postischemic cooling. Neurosci. Res. Commun., 5, 87-94.
5. Brown, R., Ollerstam, A., Johansson, B., Skott, O., Gebre-Medhin, S., Fredholm, B. & Persson, A.E. (2001) Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice. Am. J. Physiol Regul. Integr. Comp. Physiol., 281, R1362-R1367.
6. Corradetti, R., Lo Conte, G., Moroni, F., Passani, M.B. & Pepeu, G. (1984) Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur. J. Pharmacol., 104, 19-26.
7. Cronberg, T., Rytter, A., Asztely, F.S., Söder, A. & Wieloch, T. (2004) Glucose but not lactate in combination with acidosis aggravates ischemic neuronal death in vitro. Stroke, 35, 753-757.
8. Dragunow, M. & Robertson, H.A. (1987) 8-Cyclopentyl 1,3-dimethylxanthine prolongs epileptic seizures in rats. Brain Res., 417, 377-379.
9. Dunwiddie, T.V. & Fredholm, B.B. (1997) Adenosine neuromodulation. In Jacobson, K.A. & Jarvis, M.F. (Eds), Purinergic Approaches in Experimental Therapeutics. Wiley-Liss, New York, pp. 359-382.
10. Dunwiddie, T.V. & Masino, S.A. (2001) The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci., 24, 31-55.
11. Dux, E., Fastbom, J., Ungerstedt, U., Rudolphi, K. & Fredholm, B.B. (1990) Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus. Brain Res., 516, 248-256.
12. Fastbom, J., Pazos, A. & Palacios, J.M. (1987) The distribution of adenosine A1 receptors and 5′-nucleotidase in the brain of some commonly used experimental animals. Neuroscience, 22, 813-826.
13. Fowler, J.C. (1990) Adenosine antagonists alter the synaptic response to in vitro ischemia in the rat hippocampus. Brain Res., 509, 331-334.
14. Franklin, K.B.J. & Paxinos, G. (1997) The Mouse Brain Atlas in Stereotactic Coordinates. Academic Press, New York.
15. Fredholm, B.B. (1996) Adenosine and neuroprotection. In Green, A.R. & Cross, A.J. (Eds), Neuroprotective Agents and Cerebral ischemia. Academic Press, London, pp. 259-280.
16. Fredholm, B.B., Ap, I.J., Jacobson, K.A., Klotz, K.N. & Linden, J. (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev., 53, 527-552.
17. Gervitz, L.M., Davies, D.G., Omidvar, K. & Fowler, J.C. (2003) The effect of acute hypoxemia and hypotension on adenosine-mediated depression of evoked hippocampal synaptic transmission. Exp. Neurol., 182, 507-517.
18. Gimenez-Llort, L., Fernandez-Teruel, A., Escorihuela, R.M., Fredholm, B.B., Tobena, A., Pekny, M. & Johansson, B. (2002) Mice lacking the adenosine A1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate. Eur. J. Neurosci., 16, 547-550.
19. Goldberg, M.P., Monyer, H., Weiss, J.H. & Choi, D.W. (1988) Adenosine reduces cortical neuronal injury induced by oxygen or glucose deprivation in vitro. Neurosci. Lett., 89, 323-327.
20. Hagberg, H., Andersson, P., Lacarewicz, J., Jacobson, I., Butcher, S. & Sandberg, M. (1987) Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J. Neurochem., 49, 227-231.
21. Johansson, B., Halldner, L., Dunwiddie, T.V., Masino, S.A., Poelchen, W., Gimenez-Llort, L., Escorihuela, R.M., Fernandez-Teruel, A., Wiesenfeld-Hallin, Z., Xu, X.J., Hardemark, A., Betsholtz, C., Herlenius, E. & Fredholm, B.B. (2001) Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl Acad. Sci. USA, 98, 9407-9412.
22. Latini, S., Bordoni, F., Pedata, F. & Corradetti, R. (1999) Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices. Br. J. Pharmacol., 127, 729-739.
23. Lobner, D. (2002) Saturation of neuroprotective effects of adenosine in cortical culture. Neuroreport, 13, 2075-2078.
24. Lopes, L.V., Halldner, L., Rebola, N., Johansson, B., Ledent, C., Chen, J.F., Fredholm, B.B. & Cunha, R.A. (2003) Binding of the prototypical adenosine A2A receptor agonist, CGS 21680, to the cerebral cortex of adenosine A1 and A2A receptor knockout mice. Br. J. Pharmacol., 141, 1006-1014.
25. von Lubitz, D.K., Dambrosia, J.M., Kempski, O. & Redmond, D.J. (1988) Cyclohexyl adenosine protects against neuronal death following ischemia in the CA1 region of gerbil hippocampus. Stroke, 19, 1133-1139.
26. Mitchell, J.B., Miller, K. & Dunwiddie, T.V. (1993) Adenosine-induced suppression of synaptic responses and the initiation and expression of long-term potentiation in the CA1 region of the hippocampus. Hippocampus, 3, 77-86.
27. Newman, G.C., Hospod, F.E., Trowbridge, S.D., Motwani, S. & Liu, Y. (1998) Restoring adenine nucleotides in a brain slice model of cerebral reperfusion. J. Cereb. Blood Flow Metab., 18, 675-685.
28. Olsson, T., Wieloch, T. & Smith, M.L. (2003) Brain damage in a mouse model of global cerebral ischemia. Effect of NMDA receptor blockade. Brain Res., 982, 260-269.
29. Phillis, J.W. (1989) Adenosine in the control of the cerebral circulation. Cerebrovasc. Brain Metab. Rev., 1, 26-54.
30. Rossi, D.J., Oshima, T. & Attwell, D. (2000) Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature, 403, 316-321.
31. Rothman, S.M. & Olney, J.W. (1986) Glutamate and the pathophysiology of hypoxic - ischemic brain damage. Ann. Neurol., 19, 105-111.
32. Rudolphi, K.A., Keil, M., Fastbom, J. & Fredholm, B.B. (1989) Ischaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatment. Neurosci. Lett., 103, 275-280.
33. Rudolphi, K.A., Keil, M. & Hinze, H.J. (1987) Effect of theophylline on ischemically induced hippocampal damage in Mongolian gerbils: a behavioral and histopathological study. J. Cereb. Blood Flow Metab., 7, 74-81.
34. Rudolphi, K.A., Schubert, P., Parkinson, F.E. & Fredholm, B.B. (1992) Adenosine and brain ischemia. Cerebrovasc. Brain Metab. Rev., 4, 346-369.
35. Rytter, A., Cronberg, T., Asztely, F., Nemali, S. & Wieloch, T. (2003) Mouse hippocampal organotypic tissue cultures exposed to in vitro 'ischemia' show selective and delayed CA1 damage that is aggravated by glucose. J. Cereb. Blood Flow Metab., 23, 23-33.
36. Schubert, P., Ogata, T., Marchini, C., Ferroni, S. & Rudolphi, K. (1997) Protective mechanisms of adenosine in neurons and glial cells. Ann. NY Acad. Sci., 825, 1-10.
37. Stenberg, D., Litonius, E., Halldner, L., Johansson, B., Fredholm, B.B. & Porkka-Heiskanen, T. (2003) Sleep and its homeostatic regulation in mice lacking the adenosine A1 receptor. J. Sleep Res., 12, 283-290.
38. Von Lubitz, D.K., Lin, R.C., Melman, N., Ji, X.D., Carter, M.F. & Jacobson, K.A. (1994) Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia. Eur. J. Pharmacol., 256, 161-167.
39. Wieloch, T., Koide, T. & Westerberg, E. (1986) Inhibitory neurotransmitters and neuromodulators as protective agents against ischemic brain damage. In Kriegelstein, J. (Ed.), Pharmacology of Cerebral Ischemia; Proceedings of the International Symposium on Pharmacology of Cerebral Ischemia held in Marburg (FRG) on 16-17 July 1986. Elsevier Science Publishers B.V. (Biomedical Division), Marburg, Germany, pp. 191-197.
40. Wu, L.G. & Saggau, P. (1997) Presynaptic inhibition of elicited neurotransmitter release. Trends Neurosci., 20, 204-212.